Heron Therapeutics is trading 10.22% up at $0.55 in pre-market, with second-quarter results scheduled for August 10, 2026.
- The company has not announced second-quarter results; it scheduled the report and webcast for 8:30 a.m. ET.
- The upcoming earnings date may be supporting speculative interest, but causation is unconfirmed.
- No fresh August 7 catalyst, analyst action, or regulatory announcement was found.